Clorox (CLX) Financials

$94.97 -0.20 (-0.21%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$94.86 -0.11 (-0.11%)

As of 05/22/2026 07:46 PM Eastern

Annual Income Statements for Clorox

This table shows Clorox's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	0.00	648	701	823	820	939	710	462	149	280	810
Consolidated Net Income / (Loss)	0.00	648	701	823	820	939	719	471	161	292	824
Net Income / (Loss) Continuing Operations	0.00	648	703	823	820	939	719	471	161	292	824
Total Pre-Tax Income	0.00	983	1,033	1,054	1,024	1,185	900	607	238	398	1,078
Total Operating Income	0.00	1,064	1,127	1,136	1,124	1,274	927	750	408	683	1,080
Total Gross Profit	2,465	2,598	2,671	2,675	2,728	3,063	3,199	2,545	2,908	3,048	3,213
Total Revenue	0.00	5,761	5,973	6,124	6,214	6,721	7,341	7,107	7,389	7,093	7,104
Operating Revenue	-	5,761	5,973	6,124	6,214	6,721	7,341	7,107	7,389	7,093	7,104
Total Cost of Revenue	0.00	3,163	3,302	3,449	3,486	3,658	4,142	4,562	4,481	4,045	3,891
Operating Cost of Revenue	0.00	3,163	3,302	3,449	3,486	3,658	4,142	4,562	4,481	4,045	3,891
Total Operating Expenses	0.00	1,534	1,544	1,539	1,604	1,789	2,272	1,795	2,500	2,365	2,133
Selling, General & Admin Expense	0.00	806	810	837	856	969	1,004	954	1,183	1,167	1,124
Marketing Expense	0.00	587	599	570	612	675	790	709	734	832	770
Research & Development Expense	0.00	141	135	132	136	145	149	132	138	126	121
Impairment Charge	-	-	-	-	0.00	0.00	329	0.00	445	0.00	0.00
Other Special Charges / (Income)	-	-	-	-	-	-	-	0.00	0.00	240	118
Total Other Income / (Expense), net	0.00	-81	-94	-82	-100	-89	-27	-143	-170	-285	-2.00
Interest Expense	0.00	88	88	85	97	99	99	106	90	90	88
Other Income / (Expense), net	0.00	7.00	-6.00	3.00	-3.00	10	72	-37	-80	-195	86
Income Tax Expense	0.00	335	330	231	204	246	181	136	77	106	254
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	0.00	0.00	9.00	9.00	12	12	14
Basic Earnings per Share	$0.00	$5.01	$5.43	$6.37	$6.42	$7.46	$5.66	$3.75	$1.21	$2.26	$6.56
Weighted Average Basic Shares Outstanding	0.00	129.47M	128.95M	129.29M	127.73M	125.83M	125.57M	123.11M	123.59M	124.17M	123.53M
Diluted Earnings per Share	$0.00	$4.92	$5.33	$6.26	$6.32	$7.36	$5.58	$3.73	$1.20	$2.25	$6.52
Weighted Average Diluted Shares Outstanding	0.00	131.72M	131.57M	131.58M	129.79M	127.67M	127.30M	123.91M	124.18M	124.80M	124.29M
Weighted Average Basic & Diluted Shares Outstanding	130.30M	129.47M	129.10M	129.20M	127.70M	126.21M	122.81M	123.16M	123.83M	123.86M	122.31M
Cash Dividends to Common per Share	$2.99	$3.08	$3.20	$3.48	$3.84	$4.24	$4.44	$4.64	$4.72	$4.80	$4.88

This table shows Clorox's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	22	93	-51	216	99	193	186	332	80	157	187
Consolidated Net Income / (Loss)	25	96	-50	221	103	194	191	336	82	161	191
Net Income / (Loss) Continuing Operations	25	96	-50	221	103	194	191	336	82	161	191
Total Pre-Tax Income	29	136	-42	275	177	237	254	410	107	215	256
Total Operating Income	62	326	-22	317	176	236	243	425	125	241	289
Total Gross Profit	532	866	766	884	807	738	744	924	596	722	722
Total Revenue	1,386	1,990	1,814	1,903	1,762	1,686	1,668	1,988	1,429	1,673	1,670
Operating Revenue	1,386	1,990	1,814	1,903	1,762	1,686	1,668	1,988	1,429	1,673	1,670
Total Cost of Revenue	854	1,124	1,048	1,019	955	948	924	1,064	833	951	948
Operating Cost of Revenue	854	1,124	1,048	1,019	955	948	924	1,064	833	951	948
Total Operating Expenses	470	540	788	567	631	502	501	499	471	481	433
Selling, General & Admin Expense	276	322	301	268	281	280	267	296	277	262	229
Marketing Expense	165	186	215	266	201	191	207	171	166	190	177
Research & Development Expense	29	32	32	33	31	31	27	32	28	29	27
Other Special Charges / (Income)	0.00	0.00	240	-	118	0.00	0.00	-	0.00	0.00	0.00
Total Other Income / (Expense), net	-33	-190	-20	-42	1.00	1.00	11	-15	-18	-26	-33
Interest Expense	21	26	22	21	21	22	23	22	23	25	27
Other Income / (Expense), net	-12	-164	2.00	-21	22	23	34	7.00	5.00	-1.00	-6.00
Income Tax Expense	4.00	40	8.00	54	74	43	63	74	25	54	65
Net Income / (Loss) Attributable to Noncontrolling Interest	3.00	3.00	1.00	5.00	4.00	1.00	5.00	4.00	2.00	4.00	4.00
Basic Earnings per Share	$0.17	$0.75	($0.41)	$1.75	$0.80	$1.55	$1.51	$2.70	$0.65	$1.29	$1.54
Weighted Average Basic Shares Outstanding	123.97M	124.18M	124.25M	124.17M	123.80M	123.77M	123.37M	123.53M	122.63M	121.60M	121.36M
Diluted Earnings per Share	$0.17	$0.75	($0.41)	$1.74	$0.80	$1.54	$1.50	$2.68	$0.65	$1.29	$1.54
Weighted Average Diluted Shares Outstanding	124.65M	124.62M	124.25M	124.80M	124.68M	124.66M	124.07M	124.29M	123.02M	121.92M	121.79M
Weighted Average Basic & Diluted Shares Outstanding	124.06M	124.11M	124.19M	123.86M	123.78M	123.19M	123.25M	122.31M	121.98M	120.91M	120.92M
Cash Dividends to Common per Share	$2.40	$1.20	$1.20	-	$2.44	$1.22	$1.22	-	$2.48	$1.24	$1.24

This table details how cash moves in and out of Clorox's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Change in Cash & Equivalents	53	19	14	-285	-21	766	-555	-138	182	-161	-37
Net Cash From Operating Activities	874	778	865	976	992	1,546	1,276	786	1,158	695	981
Net Cash From Continuing Operating Activities	858	768	868	976	992	1,546	1,276	786	1,158	695	981
Net Income / (Loss) Continuing Operations	606	648	703	823	820	939	719	471	161	292	824
Consolidated Net Income / (Loss)	580	648	701	823	820	939	719	471	161	292	824
Depreciation Expense	169	165	163	166	180	180	211	224	236	235	219
Non-Cash Adjustments To Reconcile Net Income	-10	46	84	97	14	99	387	184	556	509	169
Changes in Operating Assets and Liabilities, net	93	-91	-82	-110	-22	328	-41	-93	205	-341	-231
Net Cash From Investing Activities	-106	-430	-205	-859	-196	-252	-452	-229	-223	-175	-94
Net Cash From Continuing Investing Activities	-106	-430	-205	-859	-196	-252	-452	-229	-223	-175	-94
Purchase of Property, Plant & Equipment	-125	-172	-231	-194	-206	-254	-331	-251	-228	-212	-220
Divestitures	-	-	-	-	-	-	-	0.00	0.00	17	128
Other Investing Activities, net	19	32	26	16	10	2.00	-36	22	5.00	20	-2.00
Net Cash From Financing Activities	-696	-316	-645	-399	-815	-523	-1,391	-689	-753	-655	-924
Net Cash From Continuing Financing Activities	-696	-316	-645	-399	-815	-523	-1,391	-689	-753	-655	-924
Repurchase of Common Equity	-434	-254	-183	-271	-661	-248	-905	-25	0.00	0.00	-332
Payment of Dividends	-385	-398	-412	-450	-490	-533	-589	-586	-598	-611	-618
Issuance of Debt	447	426	0.00	891	189	96	0.00	1,322	-	-	0.00
Issuance of Common Equity	-	210	75	45	147	162	103	5.00	33	1.00	26
Effect of Exchange Rate Changes	-19	-13	-1.00	-3.00	-2.00	-5.00	12	-6.00	0.00	-26	0.00
Cash Interest Paid	104	79	78	75	87	89	89	89	99	102	97
Cash Income Taxes Paid	236	323	347	245	207	241	303	100	73	347	264

This table details how cash moves in and out of Clorox's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	152	-162	-137	-14	75	12	-65	-59	-1.00	60	958
Net Cash From Operating Activities	20	153	182	340	221	180	286	294	93	311	-122
Net Cash From Continuing Operating Activities	20	153	182	340	221	180	286	294	93	311	-122
Net Income / (Loss) Continuing Operations	25	96	-50	221	103	194	191	336	82	161	191
Consolidated Net Income / (Loss)	25	96	-50	221	103	194	191	336	82	161	191
Depreciation Expense	61	57	58	59	54	53	55	57	56	55	58
Non-Cash Adjustments To Reconcile Net Income	14	194	274	27	120	37	10	2.00	-2.00	16	-464
Changes in Operating Assets and Liabilities, net	-80	-194	-100	33	-56	-104	30	-101	-43	79	93
Net Cash From Investing Activities	-23	-33	-38	-81	89	-54	-53	-76	-34	-43	-43
Net Cash From Continuing Investing Activities	-23	-33	-38	-81	89	-54	-53	-76	-34	-43	-43
Purchase of Property, Plant & Equipment	-24	-52	-55	-81	-39	-53	-53	-75	-36	-42	-43
Net Cash From Financing Activities	155	-259	-278	-273	-237	-109	-299	-279	-59	-210	1,126
Net Cash From Continuing Financing Activities	155	-259	-278	-273	-237	-109	-299	-279	-59	-210	1,126
Payment of Dividends	-149	-149	-148	-165	-151	-151	-166	-150	-151	-151	-150
Issuance of Debt	-	-	-	-106	0.00	-	-	-	-	-	1,278
Issuance of Common Equity	6.00	-7.00	4.00	-2.00	21	8.00	1.00	-4.00	7.00	-21	-2.00
Effect of Exchange Rate Changes	0.00	-23	-3.00	-	2.00	-5.00	1.00	2.00	-1.00	2.00	-3.00

This table presents Clorox's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Total Assets	4,164	4,510	4,573	5,060	5,116	6,213	6,334	6,158	5,945	5,751	5,561
Total Current Assets	1,429	1,485	1,514	1,311	1,305	2,020	1,829	1,725	1,828	1,622	1,608
Cash & Equivalents	382	401	418	131	111	871	319	183	367	202	167
Accounts Receivable	519	569	565	600	631	648	604	681	688	695	821
Inventories, net	385	443	459	506	512	454	752	755	696	637	523
Prepaid Expenses	-	72	72	74	51	47	154	106	77	88	97
Plant, Property, & Equipment, net	918	906	931	996	1,034	1,103	1,302	1,334	1,345	1,315	1,267
Total Noncurrent Assets	1,817	2,119	2,128	2,753	2,777	3,090	3,203	3,099	2,772	2,814	2,686
Goodwill	1,067	1,197	1,196	1,602	1,591	1,577	1,575	1,558	1,252	1,228	1,229
Intangible Assets	585	735	722	929	912	894	918	884	712	681	566
Other Noncurrent Operating Assets	165	187	210	222	274	619	710	657	808	905	891
Total Liabilities & Shareholders' Equity	4,164	4,510	4,573	5,060	5,116	6,213	6,334	6,158	5,945	5,751	5,561
Total Liabilities	4,046	4,213	4,031	4,334	4,557	5,305	5,742	5,429	5,557	5,259	5,079
Total Current Liabilities	1,405	1,558	1,809	1,200	1,440	1,418	2,056	1,784	1,917	1,574	1,919
Short-Term Debt	395	523	804	199	396	0.00	300	237	50	4.00	4.00
Accounts Payable	979	1,035	1,005	1,001	1,035	1,329	1,675	1,469	1,659	1,486	1,828
Other Current Liabilities	-	-	-	-	0.00	64	81	78	87	84	87
Total Noncurrent Liabilities	2,641	2,655	2,222	3,134	3,117	3,887	3,686	3,645	3,640	3,685	3,160
Long-Term Debt	2,546	2,573	2,161	3,062	2,287	2,780	2,484	2,474	2,477	2,481	2,484
Noncurrent Deferred & Payable Income Tax Liabilities	95	82	61	72	50	62	67	66	28	22	20
Other Noncurrent Operating Liabilities	-	-	-	-	780	1,045	1,135	1,105	1,135	1,182	656
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	118	297	542	726	559	908	592	729	388	492	482
Total Preferred & Common Equity	118	297	542	726	559	908	411	556	220	328	321
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	118	297	542	726	559	908	411	556	220	328	321
Common Stock	934	1,027	1,087	1,134	1,205	1,296	1,317	1,333	1,376	1,419	1,450
Retained Earnings	1,923	2,163	2,440	2,797	3,150	3,567	1,036	1,048	583	250	432
Treasury Stock	-2,237	-2,323	-2,442	-2,658	-3,194	-3,315	-1,396	-1,346	-1,246	-1,186	-1,404
Accumulated Other Comprehensive Income / (Loss)	-502	-570	-543	-547	-602	-640	-546	-479	-493	-155	-157
Noncontrolling Interest	-	-	-	-	-	0.00	181	173	168	164	161

This table presents Clorox's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	9/30/2025	12/31/2025	3/31/2026
Total Assets	5,945	5,991	5,908	5,805	5,751	5,497	5,577	5,512	5,528	5,613	6,436
Total Current Assets	1,828	1,911	1,804	1,661	1,622	1,576	1,632	1,590	1,695	1,728	2,651
Cash & Equivalents	367	518	355	219	202	278	290	226	166	227	1,187
Accounts Receivable	688	581	679	673	695	595	603	597	703	671	671
Inventories, net	696	710	655	674	637	594	592	635	577	608	588
Prepaid Expenses	77	102	115	95	88	109	147	132	249	222	205
Plant, Property, & Equipment, net	1,345	1,317	1,314	1,292	1,315	1,242	1,242	1,245	1,251	1,247	1,235
Total Noncurrent Assets	2,772	2,763	2,790	2,852	2,814	2,679	2,703	2,677	2,582	2,638	2,550
Goodwill	1,252	1,246	1,252	1,229	1,228	1,233	1,219	1,222	1,227	1,231	1,229
Intangible Assets	712	703	698	688	681	581	574	569	561	556	551
Other Noncurrent Operating Assets	808	814	840	935	905	865	910	886	794	851	770
Total Liabilities & Shareholders' Equity	5,945	5,991	5,908	5,805	5,751	5,497	5,577	5,512	5,528	5,613	6,436
Total Liabilities	5,557	5,860	5,690	5,550	5,259	5,273	5,456	5,322	5,390	5,578	6,344
Total Current Liabilities	1,917	2,228	2,022	1,846	1,574	1,579	1,730	2,155	2,234	2,347	3,155
Short-Term Debt	50	347	247	111	4.00	4.00	189	54	218	307	1,591
Accounts Payable	1,659	1,678	1,649	1,653	1,486	1,472	1,460	2,016	1,927	1,957	1,479
Other Current Liabilities	87	88	92	82	84	83	81	85	89	83	85
Total Noncurrent Liabilities	3,640	3,632	3,668	3,704	3,685	3,694	3,726	3,167	3,156	3,231	3,189
Long-Term Debt	2,477	2,478	2,479	2,480	2,481	2,482	2,483	2,483	2,485	2,486	2,487
Noncurrent Deferred & Payable Income Tax Liabilities	28	27	26	24	22	23	22	21	20	19	23
Other Noncurrent Operating Liabilities	1,135	1,127	1,163	1,200	1,182	1,189	1,221	663	651	726	679
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	388	131	218	255	492	224	121	190	138	35	92
Total Preferred & Common Equity	220	-37	53	91	328	60	-41	27	-22	-125	-67
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	220	-37	53	91	328	60	-41	27	-22	-125	-67
Common Stock	1,376	1,377	1,376	1,401	1,419	1,428	1,418	1,435	1,457	1,435	1,446
Retained Earnings	583	299	241	34	250	31	68	99	200	190	223
Treasury Stock	-1,246	-1,219	-1,205	-1,189	-1,186	-1,252	-1,346	-1,331	-1,514	-1,591	-1,584
Accumulated Other Comprehensive Income / (Loss)	-493	-494	-359	-155	-155	-147	-181	-176	-165	-159	-152
Noncontrolling Interest	168	168	165	164	164	164	162	163	160	160	159

This table displays calculated financial ratios and metrics derived from Clorox's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.56%	1.87%	3.68%	2.53%	1.47%	8.16%	9.22%	-3.19%	3.97%	-4.01%	0.16%
EBITDA Growth	2.34%	-78.78%	3.88%	1.64%	-0.31%	12.53%	-17.35%	-22.56%	-39.81%	28.19%	91.56%
EBIT Growth	2.56%	-81.06%	4.67%	1.61%	-1.58%	14.54%	-22.20%	-28.63%	-54.00%	48.78%	138.93%
NOPAT Growth	2.56%	-82.28%	9.35%	15.65%	1.47%	12.16%	-26.64%	-21.42%	-52.57%	81.56%	64.74%
Net Income Growth	3.94%	11.72%	8.18%	17.40%	-0.36%	14.51%	-23.43%	-34.49%	-65.82%	81.37%	182.19%
EPS Growth	0.00%	0.00%	8.33%	17.45%	0.96%	16.46%	-24.18%	-33.15%	-67.83%	87.50%	189.78%
Operating Cash Flow Growth	13.95%	-10.98%	11.18%	12.83%	1.64%	55.85%	-17.46%	-38.40%	47.33%	-39.98%	41.15%
Free Cash Flow Firm Growth	-13.23%	-88.70%	73.39%	-82.08%	1,253.91%	-18.56%	-62.18%	-23.69%	157.88%	-72.17%	190.97%
Invested Capital Growth	25.21%	11.77%	3.24%	24.83%	-18.80%	-10.03%	8.52%	6.54%	-21.77%	8.91%	1.01%
Revenue Q/Q Growth	1.07%	0.75%	0.79%	0.72%	-1.02%	5.59%	-2.41%	-0.01%	3.04%	-1.61%	1.21%
EBITDA Q/Q Growth	2.21%	-79.09%	3.46%	1.24%	-0.84%	7.57%	-19.17%	4.81%	20.77%	5.09%	10.71%
EBIT Q/Q Growth	2.33%	-81.36%	4.09%	1.15%	-1.15%	8.72%	-22.74%	5.94%	38.98%	8.44%	13.20%
NOPAT Q/Q Growth	-12.45%	-81.69%	6.15%	1.87%	2.51%	5.33%	-19.47%	2.20%	39.13%	10.13%	12.96%
Net Income Q/Q Growth	3.76%	-3.86%	5.41%	1.98%	3.02%	7.93%	-22.61%	0.86%	91.67%	15.87%	16.22%
EPS Q/Q Growth	100.00%	564.86%	5.34%	2.29%	3.27%	8.24%	-22.28%	0.00%	103.39%	15.98%	16.85%
Operating Cash Flow Q/Q Growth	5.05%	-5.81%	6.40%	1.77%	-1.10%	29.37%	-21.86%	-5.76%	8.94%	-11.47%	-4.48%
Free Cash Flow Firm Q/Q Growth	-27.00%	-89.96%	265.22%	-84.53%	755.06%	-27.18%	-38.63%	-34.31%	13.04%	-26.32%	-6.92%
Invested Capital Q/Q Growth	28.09%	44.33%	-3.50%	16.99%	-21.41%	-9.86%	-5.33%	1.24%	0.16%	5.63%	12.08%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	43.59%	45.10%	44.72%	43.68%	43.90%	45.57%	43.58%	35.81%	39.36%	42.97%	45.23%
EBITDA Margin	102.99%	21.45%	21.50%	21.31%	20.94%	21.78%	16.48%	13.18%	7.63%	10.19%	19.50%
Operating Margin	100.00%	18.47%	18.87%	18.55%	18.09%	18.96%	12.63%	10.55%	5.52%	9.63%	15.20%
EBIT Margin	100.00%	18.59%	18.77%	18.60%	18.04%	19.10%	13.61%	10.03%	4.44%	6.88%	16.41%
Profit (Net Income) Margin	10.26%	11.25%	11.74%	13.44%	13.20%	13.97%	9.79%	6.63%	2.18%	4.12%	11.60%
Tax Burden Percent	0.00%	65.92%	67.86%	78.08%	80.08%	79.24%	79.89%	77.59%	67.65%	73.37%	76.44%
Interest Burden Percent	0.00%	91.78%	92.15%	92.54%	91.35%	92.29%	90.09%	85.13%	72.56%	81.56%	92.45%
Effective Tax Rate	0.00%	34.08%	31.95%	21.92%	19.92%	20.76%	20.11%	22.41%	32.35%	26.63%	23.56%
Return on Invested Capital (ROIC)	164.42%	24.75%	25.23%	25.54%	25.76%	33.95%	25.22%	18.43%	9.51%	18.83%	29.60%
ROIC Less NNEP Spread (ROIC-NNEP)	15.69%	22.71%	22.71%	23.29%	22.96%	30.80%	24.23%	13.99%	4.60%	9.42%	29.53%
Return on Net Nonoperating Assets (RNNOA)	262.05%	287.54%	141.88%	104.27%	101.86%	94.07%	70.65%	52.88%	19.32%	47.54%	139.60%
Return on Equity (ROE)	426.47%	312.29%	167.10%	129.81%	127.63%	128.02%	95.87%	71.31%	28.83%	66.36%	169.20%
Cash Return on Invested Capital (CROIC)	142.04%	13.63%	22.03%	3.46%	46.52%	44.50%	17.04%	12.10%	33.94%	10.30%	28.60%
Operating Return on Assets (OROA)	134.29%	24.69%	24.68%	23.65%	22.03%	22.67%	15.92%	11.42%	5.42%	8.34%	20.62%
Return on Assets (ROA)	13.77%	14.94%	15.44%	17.09%	16.12%	16.58%	11.46%	7.54%	2.66%	4.99%	14.57%
Return on Common Equity (ROCE)	426.47%	312.29%	167.10%	129.81%	127.63%	128.02%	84.30%	52.20%	20.03%	41.33%	112.74%
Return on Equity Simple (ROE_SIMPLE)	491.53%	218.18%	129.34%	113.36%	146.69%	103.41%	174.94%	84.71%	73.18%	89.02%	0.00%
Net Operating Profit after Tax (NOPAT)	3,959	701	767	887	900	1,010	741	582	276	501	826
NOPAT Margin	70.00%	12.17%	12.84%	14.48%	14.48%	15.02%	10.09%	8.19%	3.74%	7.06%	11.62%
Net Nonoperating Expense Percent (NNEP)	148.73%	2.03%	2.52%	2.26%	2.81%	3.15%	0.99%	4.44%	4.91%	9.41%	0.07%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	27.80%
Cost of Revenue to Revenue	0.00%	54.90%	55.28%	56.32%	56.10%	54.43%	56.42%	64.19%	60.64%	57.03%	54.77%
SG&A Expenses to Revenue	0.00%	13.99%	13.56%	13.67%	13.78%	14.42%	13.68%	13.42%	16.01%	16.45%	15.82%
R&D to Revenue	0.00%	2.45%	2.26%	2.16%	2.19%	2.16%	2.03%	1.86%	1.87%	1.78%	1.70%
Operating Expenses to Revenue	0.00%	26.63%	25.85%	25.13%	25.81%	26.62%	30.95%	25.26%	33.83%	33.34%	30.03%
Earnings before Interest and Taxes (EBIT)	5,655	1,071	1,121	1,139	1,121	1,284	999	713	328	488	1,166
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5,824	1,236	1,284	1,305	1,301	1,464	1,210	937	564	723	1,385
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	89.80	48.01	25.86	20.25	30.06	26.89	49.15	28.97	85.65	51.23	45.64
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.87	2.47	2.35	2.40	2.70	3.63	2.75	2.27	2.55	2.37	2.06
Price to Earnings (P/E)	1.88	22.00	20.00	17.86	20.49	26.01	28.45	34.86	126.46	60.01	18.09
Dividend Yield	3.66%	2.79%	2.94%	3.07%	2.91%	2.19%	2.73%	3.55%	3.10%	3.55%	4.11%
Earnings Yield	53.12%	4.54%	5.00%	5.60%	4.88%	3.85%	3.51%	2.87%	0.79%	1.67%	5.53%
Enterprise Value to Invested Capital (EV/IC)	4.91	5.67	5.36	4.62	6.19	9.35	7.47	5.77	8.31	6.94	6.11
Enterprise Value to Revenue (EV/Rev)	2.33	2.94	2.77	2.91	3.12	3.92	3.11	2.65	2.87	2.71	2.41
Enterprise Value to EBITDA (EV/EBITDA)	2.26	13.72	12.90	13.67	14.89	17.98	18.88	20.07	37.54	26.63	12.37
Enterprise Value to EBIT (EV/EBIT)	2.33	15.83	14.78	15.66	17.28	20.51	22.87	26.38	64.54	39.45	14.69
Enterprise Value to NOPAT (EV/NOPAT)	3.32	24.17	21.60	20.10	21.52	26.08	30.85	32.32	76.71	38.42	20.75
Enterprise Value to Operating Cash Flow (EV/OCF)	15.05	21.79	19.15	18.27	19.53	17.03	17.91	23.93	18.28	27.70	17.46
Enterprise Value to Free Cash Flow (EV/FCFF)	3.85	43.87	24.73	148.57	11.92	19.89	45.64	49.24	21.49	70.23	21.48
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	24.92	10.42	5.47	4.49	4.80	3.06	4.70	3.72	6.51	5.05	5.16
Long-Term Debt to Equity	21.58	8.66	3.99	4.22	4.09	3.06	4.20	3.39	6.38	5.04	5.15
Financial Leverage	16.70	12.66	6.25	4.48	4.44	3.05	2.92	3.78	4.20	5.05	4.73
Leverage Ratio	30.96	20.90	10.83	7.60	7.92	7.72	8.36	9.46	10.84	13.29	11.61
Compound Leverage Factor	0.00	19.18	9.98	7.03	7.23	7.13	7.54	8.05	7.86	10.84	10.74
Debt to Total Capital	96.14%	91.25%	84.55%	81.79%	82.76%	75.38%	82.46%	78.81%	86.69%	83.47%	83.77%
Short-Term Debt to Total Capital	12.91%	15.41%	22.93%	4.99%	12.21%	0.00%	8.89%	6.89%	1.72%	0.13%	0.13%
Long-Term Debt to Total Capital	83.23%	75.83%	61.62%	76.80%	70.54%	75.38%	73.58%	71.92%	84.97%	83.34%	83.64%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.36%	5.03%	5.76%	5.51%	5.42%
Common Equity to Total Capital	3.86%	8.75%	15.45%	18.21%	17.24%	24.62%	12.17%	16.16%	7.55%	11.02%	10.81%
Debt to EBITDA	0.51	2.50	2.31	2.50	2.06	1.90	2.30	2.89	4.48	3.44	1.80
Net Debt to EBITDA	0.44	2.18	1.98	2.40	1.98	1.30	2.04	2.70	3.83	3.16	1.68
Long-Term Debt to EBITDA	0.44	2.08	1.68	2.35	1.76	1.90	2.05	2.64	4.39	3.43	1.79
Debt to NOPAT	0.74	4.41	3.87	3.68	2.98	2.75	3.76	4.66	9.16	4.96	3.01
Net Debt to NOPAT	0.65	3.84	3.32	3.53	2.86	1.89	3.33	4.34	7.83	4.56	2.81
Long-Term Debt to NOPAT	0.64	3.67	2.82	3.45	2.54	2.75	3.35	4.25	8.97	4.95	3.01
Altman Z-Score	8.06	4.74	4.87	4.79	4.98	5.45	3.98	3.54	3.58	3.50	3.74
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12.07%	26.80%	30.53%	37.73%	33.37%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.02	0.95	0.84	1.09	0.91	1.42	0.89	0.97	0.95	1.03	0.84
Quick Ratio	0.64	0.62	0.54	0.61	0.52	1.07	0.45	0.48	0.55	0.57	0.51
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	3,420	386	670	120	1,625	1,324	501	382	985	274	798
Operating Cash Flow to CapEx	699.20%	452.33%	374.46%	503.09%	481.55%	608.66%	385.50%	313.15%	507.89%	327.83%	445.91%
Free Cash Flow to Firm to Interest Expense	0.00	4.39	7.61	1.41	16.75	13.37	5.06	3.60	10.94	3.05	9.06
Operating Cash Flow to Interest Expense	0.00	8.84	9.83	11.48	10.23	15.62	12.89	7.42	12.87	7.72	11.15
Operating Cash Flow Less CapEx to Interest Expense	0.00	6.89	7.20	9.20	8.10	13.05	9.55	5.05	10.33	5.37	8.65
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.34	1.33	1.32	1.27	1.22	1.19	1.17	1.14	1.22	1.21	1.26
Accounts Receivable Turnover	10.62	10.59	10.53	10.51	10.10	10.51	11.73	11.06	10.79	10.26	9.37
Inventory Turnover	0.00	7.64	7.32	7.15	6.85	7.57	6.87	6.05	6.18	6.07	6.71
Fixed Asset Turnover	5.97	6.32	6.50	6.36	6.12	6.29	6.10	5.39	5.52	5.33	5.50
Accounts Payable Turnover	0.00	3.14	3.24	3.44	3.42	3.09	2.76	2.90	2.87	2.57	2.35
Days Sales Outstanding (DSO)	34.37	34.47	34.65	34.72	36.15	34.73	31.13	33.00	33.81	35.58	38.95
Days Inventory Outstanding (DIO)	0.00	47.77	49.85	51.06	53.29	48.19	53.14	60.29	59.10	60.14	54.41
Days Payable Outstanding (DPO)	0.00	116.20	112.75	106.15	106.59	117.94	132.36	125.77	127.40	141.89	155.44
Cash Conversion Cycle (CCC)	34.37	-33.96	-28.25	-20.37	-17.14	-35.02	-48.10	-32.49	-34.49	-46.17	-62.08
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,677	2,992	3,089	3,856	3,131	2,817	3,057	3,257	2,548	2,775	2,803
Invested Capital Turnover	2.35	2.03	1.96	1.76	1.78	2.26	2.50	2.25	2.55	2.67	2.55
Increase / (Decrease) in Invested Capital	539	315	97	767	-725	-314	240	200	-709	227	28
Enterprise Value (EV)	13,155	16,953	16,566	17,833	19,373	26,329	22,847	18,806	21,171	19,251	17,132
Market Capitalization	10,596	14,258	14,019	14,703	16,801	24,420	20,201	16,105	18,843	16,804	14,650
Book Value per Share	$0.90	$2.30	$4.21	$5.61	$4.39	$7.21	$3.30	$4.52	$1.78	$2.64	$2.60
Tangible Book Value per Share	($11.69)	($12.64)	($10.68)	($13.94)	($15.26)	($12.41)	($16.74)	($15.32)	($14.11)	($12.73)	($11.96)
Total Capital	3,059	3,393	3,507	3,987	3,242	3,688	3,376	3,440	2,915	2,977	2,970
Total Debt	2,941	3,096	2,965	3,261	2,683	2,780	2,784	2,711	2,527	2,485	2,488
Total Long-Term Debt	2,546	2,573	2,161	3,062	2,287	2,780	2,484	2,474	2,477	2,481	2,484
Net Debt	2,559	2,695	2,547	3,130	2,572	1,909	2,465	2,528	2,160	2,283	2,321
Capital Expenditures (CapEx)	125	172	231	194	206	254	331	251	228	212	220
Debt-free, Cash-free Net Working Capital (DFCFNWC)	37	49	91	179	150	-269	-246	-5.00	-406	-150	-474
Debt-free Net Working Capital (DFNWC)	419	450	509	310	261	602	73	178	-39	52	-307
Net Working Capital (NWC)	24	-73	-295	111	-135	602	-227	-59	-89	48	-311
Net Nonoperating Expense (NNE)	3,379	53	66	64	80	71	22	111	115	209	1.53
Net Nonoperating Obligations (NNO)	2,559	2,695	2,547	3,130	2,572	1,909	2,465	2,528	2,160	2,283	2,321
Total Depreciation and Amortization (D&A)	169	165	163	166	180	180	211	224	236	235	219
Debt-free, Cash-free Net Working Capital to Revenue	0.65%	0.85%	1.52%	2.92%	2.41%	-4.00%	-3.35%	-0.07%	-5.49%	-2.11%	-6.67%
Debt-free Net Working Capital to Revenue	7.41%	7.81%	8.52%	5.06%	4.20%	8.96%	0.99%	2.50%	-0.53%	0.73%	-4.32%
Net Working Capital to Revenue	0.42%	-1.27%	-4.94%	1.81%	-2.17%	8.96%	-3.09%	-0.83%	-1.20%	0.68%	-4.38%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.45	$5.01	$0.00	$0.00	$6.42	$7.46	$5.66	$3.75	$1.21	$2.26	$6.56
Adjusted Weighted Average Basic Shares Outstanding	130.31M	129.47M	0.00	0.00	127.73M	125.83M	125.57M	123.11M	123.59M	124.17M	123.53M
Adjusted Diluted Earnings per Share	$4.37	$4.92	$0.00	$0.00	$6.32	$7.36	$5.58	$3.73	$1.20	$2.25	$6.52
Adjusted Weighted Average Diluted Shares Outstanding	132.78M	131.72M	0.00	0.00	129.79M	127.67M	127.30M	123.91M	124.18M	124.80M	124.29M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	128.64M	129.47M	0.00	0.00	125.74M	126.21M	122.81M	123.16M	123.83M	123.86M	122.31M
Normalized Net Operating Profit after Tax (NOPAT)	3,959	701	767	887	900	1,010	1,003	582	577	677	916
Normalized NOPAT Margin	70.00%	12.17%	12.84%	14.48%	14.48%	15.02%	13.67%	8.19%	7.81%	9.55%	12.89%
Pre Tax Income Margin	0.00%	17.06%	17.29%	17.21%	16.48%	17.63%	12.26%	8.54%	3.22%	5.61%	15.17%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	12.17	12.74	13.40	11.56	12.97	10.09	6.73	3.64	5.42	13.25
NOPAT to Interest Expense	0.00	7.97	8.72	10.44	9.28	10.20	7.48	5.49	3.07	5.57	9.38
EBIT Less CapEx to Interest Expense	0.00	10.22	10.11	11.12	9.43	10.40	6.75	4.36	1.11	3.07	10.75
NOPAT Less CapEx to Interest Expense	0.00	6.02	6.09	8.15	7.16	7.63	4.14	3.12	0.53	3.21	6.88
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	66.38%	61.42%	58.77%	54.68%	59.76%	56.76%	81.92%	124.42%	371.43%	209.25%	75.00%
Augmented Payout Ratio	141.21%	100.62%	84.88%	87.61%	140.37%	83.17%	207.79%	129.72%	371.43%	209.25%	115.29%

This table displays calculated financial ratios and metrics derived from Clorox's official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	120,911,863.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	120,911,863.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.55
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-20.34%	16.04%	-5.27%	-5.75%	27.13%	-15.28%	-8.05%	4.47%	-18.90%	-0.77%	0.12%
EBITDA Growth	-42.78%	3.79%	123.60%	10.94%	127.03%	42.47%	773.68%	37.75%	-26.19%	-5.45%	2.71%
EBIT Growth	-63.77%	5.88%	90.95%	14.73%	296.00%	59.88%	1,485.00%	45.95%	-34.34%	-7.34%	2.17%
NOPAT Growth	-58.57%	96.84%	88.83%	17.45%	91.62%	-16.05%	1,286.55%	36.72%	-6.47%	-6.58%	18.00%
Net Income Growth	-71.26%	-5.88%	76.08%	22.10%	312.00%	102.08%	482.00%	52.04%	-20.39%	-17.01%	0.00%
EPS Growth	-75.00%	-6.25%	76.02%	21.68%	370.59%	105.33%	465.85%	54.02%	-18.75%	-16.23%	2.67%
Operating Cash Flow Growth	-88.76%	-26.79%	-46.63%	-20.93%	1,005.00%	17.65%	57.14%	-13.53%	-57.92%	72.78%	-142.66%
Free Cash Flow Firm Growth	122.52%	134.42%	-118.39%	-97.00%	-83.48%	-56.99%	413.75%	1,054.09%	-235.78%	-70.46%	-186.28%
Invested Capital Growth	-19.83%	-13.93%	3.26%	8.91%	-0.25%	-3.32%	-4.80%	1.01%	9.99%	3.92%	19.27%
Revenue Q/Q Growth	-31.35%	43.58%	-8.84%	4.91%	-7.41%	-4.31%	-1.07%	19.18%	-28.12%	17.07%	-0.18%
EBITDA Q/Q Growth	-65.31%	97.30%	-82.65%	834.21%	-29.01%	23.81%	6.41%	47.29%	-61.96%	58.60%	15.59%
EBIT Q/Q Growth	-80.62%	224.00%	-112.35%	1,580.00%	-33.11%	30.81%	6.95%	55.96%	-69.91%	84.62%	17.92%
NOPAT Q/Q Growth	-75.36%	330.54%	-106.69%	1,754.24%	-59.80%	88.62%	-5.41%	90.61%	-72.50%	88.39%	19.48%
Net Income Q/Q Growth	-86.19%	284.00%	-152.08%	542.00%	-53.39%	88.35%	-1.55%	75.92%	-75.60%	96.34%	18.63%
EPS Q/Q Growth	-88.11%	341.18%	-154.67%	524.39%	-54.02%	92.50%	-2.60%	78.67%	-75.75%	98.46%	19.38%
Operating Cash Flow Q/Q Growth	-95.35%	665.00%	18.95%	86.81%	-35.00%	-18.55%	58.89%	2.80%	-68.37%	234.41%	-139.23%
Free Cash Flow Firm Q/Q Growth	-29.10%	-1.12%	-115.16%	128.20%	290.66%	157.50%	10.58%	3.75%	-145.96%	156.02%	-423.00%
Invested Capital Q/Q Growth	-4.32%	6.19%	1.47%	5.63%	-12.36%	2.92%	-0.08%	12.08%	-4.57%	-2.77%	14.69%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	38.38%	43.52%	42.23%	46.45%	45.80%	43.77%	44.60%	46.48%	41.71%	43.16%	43.23%
EBITDA Margin	8.01%	11.01%	2.09%	18.65%	14.30%	18.51%	19.90%	24.60%	13.02%	17.63%	20.42%
Operating Margin	4.47%	16.38%	-1.21%	16.66%	9.99%	14.00%	14.57%	21.38%	8.75%	14.41%	17.31%
EBIT Margin	3.61%	8.14%	-1.10%	15.55%	11.24%	15.36%	16.61%	21.73%	9.10%	14.35%	16.95%
Profit (Net Income) Margin	1.80%	4.82%	-2.76%	11.61%	5.85%	11.51%	11.45%	16.90%	5.74%	9.62%	11.44%
Tax Burden Percent	86.21%	70.59%	119.05%	80.36%	58.19%	81.86%	75.20%	81.95%	76.64%	74.88%	74.61%
Interest Burden Percent	58.00%	83.95%	210.00%	92.91%	89.39%	91.51%	91.70%	94.91%	82.31%	89.58%	90.46%
Effective Tax Rate	13.79%	29.41%	0.00%	19.64%	41.81%	18.14%	24.80%	18.05%	23.36%	25.12%	25.39%
Return on Invested Capital (ROIC)	9.90%	30.21%	-2.37%	35.68%	17.83%	32.25%	29.99%	44.63%	17.78%	28.57%	31.83%
ROIC Less NNEP Spread (ROIC-NNEP)	8.73%	24.72%	-3.83%	34.16%	17.86%	32.28%	30.34%	44.09%	17.19%	27.78%	30.88%
Return on Net Nonoperating Assets (RNNOA)	67.56%	170.41%	-42.50%	172.46%	227.09%	452.58%	319.31%	208.42%	225.38%	881.09%	569.72%
Return on Equity (ROE)	77.46%	200.62%	-44.87%	208.13%	244.92%	484.83%	349.30%	253.04%	243.15%	909.65%	601.55%
Cash Return on Invested Capital (CROIC)	29.14%	25.03%	14.39%	10.30%	22.43%	23.46%	33.42%	28.60%	22.59%	27.80%	13.12%
Operating Return on Assets (OROA)	4.18%	9.96%	-1.37%	18.87%	14.61%	19.17%	20.60%	27.29%	11.17%	17.33%	19.18%
Return on Assets (ROA)	2.09%	5.90%	-3.42%	14.09%	7.60%	14.36%	14.20%	21.23%	7.05%	11.62%	12.94%
Return on Common Equity (ROCE)	35.70%	105.83%	-9.88%	129.61%	15.87%	17.16%	92.62%	168.61%	25.52%	-967.96%	-85.33%
Return on Equity Simple (ROE_SIMPLE)	-267.57%	175.47%	276.92%	0.00%	616.67%	-1,141.46%	2,625.93%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	53	230	-15	255	102	193	183	348	96	180	216
NOPAT Margin	3.86%	11.56%	-0.85%	13.39%	5.81%	11.46%	10.95%	17.52%	6.70%	10.79%	12.91%
Net Nonoperating Expense Percent (NNEP)	1.17%	5.49%	1.46%	1.52%	-0.03%	-0.03%	-0.35%	0.53%	0.58%	0.79%	0.95%
Return On Investment Capital (ROIC_SIMPLE)	-	7.82%	-	-	-	6.92%	6.70%	11.73%	3.37%	6.38%	5.17%
Cost of Revenue to Revenue	61.62%	56.48%	57.77%	53.55%	54.20%	56.23%	55.40%	53.52%	58.29%	56.84%	56.77%
SG&A Expenses to Revenue	19.91%	16.18%	16.59%	14.08%	15.95%	16.61%	16.01%	14.89%	19.38%	15.66%	13.71%
R&D to Revenue	2.09%	1.61%	1.76%	1.73%	1.76%	1.84%	1.62%	1.61%	1.96%	1.73%	1.62%
Operating Expenses to Revenue	33.91%	27.14%	43.44%	29.80%	35.81%	29.77%	30.04%	25.10%	32.96%	28.75%	25.93%
Earnings before Interest and Taxes (EBIT)	50	162	-20	296	198	259	277	432	130	240	283
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	111	219	38	355	252	312	332	489	186	295	341
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	320.47	205.33	51.23	333.73	0.00	666.07	45.64	0.00	0.00	0.00
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.21	2.32	2.59	2.37	2.68	2.78	2.56	2.06	2.20	1.80	1.83
Price to Earnings (P/E)	180.79	212.31	77.85	60.01	56.09	43.65	25.91	18.09	18.87	16.11	16.37
Dividend Yield	3.78%	3.48%	3.17%	3.55%	2.98%	3.00%	3.33%	4.11%	4.02%	4.93%	4.83%
Earnings Yield	0.55%	0.47%	1.28%	1.67%	1.78%	2.29%	3.86%	5.53%	5.30%	6.21%	6.11%
Enterprise Value to Invested Capital (EV/IC)	7.39	7.54	8.08	6.94	9.21	8.99	8.18	6.11	6.59	5.72	5.17
Enterprise Value to Revenue (EV/Rev)	2.56	2.67	2.94	2.71	3.00	3.14	2.91	2.41	2.60	2.20	2.28
Enterprise Value to EBITDA (EV/EBITDA)	37.47	39.92	30.84	26.63	25.92	23.50	16.35	12.37	13.36	11.44	11.77
Enterprise Value to EBIT (EV/EBIT)	75.10	78.40	47.16	39.45	35.21	30.69	19.86	14.69	16.05	13.80	14.22
Enterprise Value to NOPAT (EV/NOPAT)	92.25	69.38	46.64	38.42	41.47	43.98	27.99	20.75	21.50	18.44	18.33
Enterprise Value to Operating Cash Flow (EV/OCF)	18.02	20.68	27.03	27.70	25.00	24.37	19.92	17.46	20.66	15.13	26.78
Enterprise Value to Free Cash Flow (EV/FCFF)	22.57	27.87	57.05	70.23	41.01	37.65	23.88	21.48	30.55	20.99	42.88
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	21.56	12.50	10.16	5.05	11.10	22.08	13.35	5.16	19.59	79.80	44.33
Long-Term Debt to Equity	18.92	11.37	9.73	5.04	11.08	20.52	13.07	5.15	18.01	71.03	27.03
Financial Leverage	7.74	6.89	11.11	5.05	12.72	14.02	10.52	4.73	13.11	31.72	18.45
Leverage Ratio	19.37	16.86	27.22	13.29	32.36	33.88	25.43	11.61	30.46	71.73	42.37
Compound Leverage Factor	11.23	14.15	57.16	12.35	28.93	31.00	23.32	11.02	25.07	64.26	38.33
Debt to Total Capital	95.57%	92.60%	91.04%	83.47%	91.73%	95.67%	93.03%	83.77%	95.14%	98.76%	97.79%
Short-Term Debt to Total Capital	11.74%	8.39%	3.90%	0.13%	0.15%	6.77%	1.98%	0.13%	7.67%	10.86%	38.15%
Long-Term Debt to Total Capital	83.83%	84.21%	87.14%	83.34%	91.59%	88.90%	91.05%	83.64%	87.47%	87.91%	59.64%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	5.68%	5.60%	5.76%	5.51%	6.05%	5.80%	5.98%	5.42%	5.63%	5.66%	3.81%
Common Equity to Total Capital	-1.25%	1.80%	3.20%	11.02%	2.21%	-1.47%	0.99%	10.81%	-0.77%	-4.42%	-1.61%
Debt to EBITDA	5.87	5.57	3.77	3.44	2.88	2.79	2.03	1.80	2.05	2.15	3.11
Net Debt to EBITDA	4.80	4.85	3.45	3.16	2.56	2.49	1.85	1.68	1.92	1.97	2.21
Long-Term Debt to EBITDA	5.15	5.07	3.60	3.43	2.87	2.59	1.98	1.79	1.88	1.91	1.90
Debt to NOPAT	14.46	9.69	5.69	4.96	4.60	5.22	3.47	3.01	3.30	3.46	4.85
Net Debt to NOPAT	11.81	8.43	5.21	4.56	4.09	4.66	3.16	2.81	3.09	3.18	3.43
Long-Term Debt to NOPAT	12.68	8.81	5.45	4.95	4.60	4.86	3.40	3.01	3.03	3.08	2.95
Altman Z-Score	2.80	3.13	3.22	3.39	3.76	3.63	3.37	3.31	2.90	2.57	2.32
Noncontrolling Interest Sharing Ratio	53.91%	47.25%	77.99%	37.73%	93.52%	96.46%	73.48%	33.37%	89.50%	206.41%	114.18%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.86	0.89	0.90	1.03	1.00	0.94	0.74	0.84	0.76	0.74	0.84
Quick Ratio	0.49	0.51	0.48	0.57	0.55	0.52	0.38	0.51	0.39	0.38	0.59
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	656	649	-98	28	108	279	309	320	-147	82	-266
Operating Cash Flow to CapEx	83.33%	294.23%	330.91%	419.75%	566.67%	339.62%	539.62%	392.00%	258.33%	740.48%	-283.72%
Free Cash Flow to Firm to Interest Expense	31.26	24.97	-4.47	1.32	5.16	12.69	13.42	14.56	-6.40	3.30	-9.87
Operating Cash Flow to Interest Expense	0.95	5.88	8.27	16.19	10.52	8.18	12.43	13.36	4.04	12.44	-4.52
Operating Cash Flow Less CapEx to Interest Expense	-0.19	3.88	5.77	12.33	8.67	5.77	10.13	9.95	2.48	10.76	-6.11
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.16	1.22	1.24	1.21	1.30	1.25	1.24	1.26	1.23	1.21	1.13
Accounts Receivable Turnover	11.79	11.43	10.67	10.26	12.70	11.18	11.05	9.37	10.43	10.61	10.66
Inventory Turnover	5.76	6.09	5.94	6.07	6.36	6.37	5.88	6.71	6.44	6.29	6.21
Fixed Asset Turnover	5.33	5.55	5.53	5.33	5.84	5.61	5.53	5.50	5.43	5.43	5.45
Accounts Payable Turnover	2.59	2.63	2.48	2.57	2.63	2.55	2.10	2.35	2.22	2.21	2.17
Days Sales Outstanding (DSO)	30.95	31.93	34.20	35.58	28.73	32.65	33.02	38.95	34.99	34.40	34.23
Days Inventory Outstanding (DIO)	63.34	59.95	61.47	60.14	57.40	57.32	62.11	54.41	56.70	58.06	58.80
Days Payable Outstanding (DPO)	141.04	139.04	147.25	141.89	138.66	142.92	174.10	155.44	164.58	165.32	168.03
Cash Conversion Cycle (CCC)	-46.75	-47.17	-51.57	-46.17	-52.52	-52.94	-78.97	-62.08	-72.90	-72.86	-75.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,438	2,589	2,627	2,775	2,432	2,503	2,501	2,803	2,675	2,601	2,983
Invested Capital Turnover	2.57	2.61	2.79	2.67	3.07	2.81	2.74	2.55	2.65	2.65	2.47
Increase / (Decrease) in Invested Capital	-603	-419	83	227	-6.00	-86	-126	28	243	98	482
Enterprise Value (EV)	18,023	19,521	21,221	19,251	22,396	22,494	20,458	17,132	17,622	14,891	15,424
Market Capitalization	15,548	16,985	18,685	16,804	20,024	19,950	17,984	14,650	14,925	12,165	12,374
Book Value per Share	($0.30)	$0.43	$0.73	$2.64	$0.48	($0.33)	$0.22	$2.60	($0.18)	($1.02)	($0.55)
Tangible Book Value per Share	($16.04)	($15.29)	($14.71)	($12.73)	($14.16)	($14.82)	($14.32)	($11.96)	($14.80)	($15.67)	($15.28)
Total Capital	2,956	2,944	2,846	2,977	2,710	2,793	2,727	2,970	2,841	2,828	4,170
Total Debt	2,825	2,726	2,591	2,485	2,486	2,672	2,537	2,488	2,703	2,793	4,078
Total Long-Term Debt	2,478	2,479	2,480	2,481	2,482	2,483	2,483	2,484	2,485	2,486	2,487
Net Debt	2,307	2,371	2,372	2,283	2,208	2,382	2,311	2,321	2,537	2,566	2,891
Capital Expenditures (CapEx)	24	52	55	81	39	53	53	75	36	42	43
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-488	-326	-293	-150	-277	-199	-737	-474	-487	-539	-100
Debt-free Net Working Capital (DFNWC)	30	29	-74	52	1.00	91	-511	-307	-321	-312	1,087
Net Working Capital (NWC)	-317	-218	-185	48	-3.00	-98	-565	-311	-539	-619	-504
Net Nonoperating Expense (NNE)	28	134	35	34	-0.58	-0.82	-8.27	12	14	19	25
Net Nonoperating Obligations (NNO)	2,307	2,371	2,372	2,283	2,208	2,382	2,311	2,321	2,537	2,566	2,891
Total Depreciation and Amortization (D&A)	61	57	58	59	54	53	55	57	56	55	58
Debt-free, Cash-free Net Working Capital to Revenue	-6.94%	-4.46%	-4.06%	-2.11%	-3.71%	-2.78%	-10.50%	-6.67%	-7.19%	-7.98%	-1.48%
Debt-free Net Working Capital to Revenue	0.43%	0.40%	-1.03%	0.73%	0.01%	1.27%	-7.28%	-4.32%	-4.74%	-4.62%	16.08%
Net Working Capital to Revenue	-4.51%	-2.98%	-2.57%	0.68%	-0.04%	-1.37%	-8.05%	-4.38%	-7.96%	-9.16%	-7.46%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.17	$0.75	($0.41)	$1.75	$0.80	$1.55	$1.51	$2.70	$0.65	$1.29	$1.54
Adjusted Weighted Average Basic Shares Outstanding	123.97M	124.18M	124.25M	124.17M	123.80M	123.77M	123.37M	123.53M	122.63M	121.60M	121.36M
Adjusted Diluted Earnings per Share	$0.17	$0.75	($0.41)	$1.74	$0.80	$1.54	$1.50	$2.68	$0.65	$1.29	$1.54
Adjusted Weighted Average Diluted Shares Outstanding	124.65M	124.62M	124.25M	124.80M	124.68M	124.66M	124.07M	124.29M	123.02M	121.92M	121.79M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	124.06M	124.11M	124.19M	123.86M	123.78M	123.19M	123.25M	122.31M	121.98M	120.91M	120.92M
Normalized Net Operating Profit after Tax (NOPAT)	53	230	153	255	171	193	183	348	96	180	216
Normalized NOPAT Margin	3.86%	11.56%	8.41%	13.39%	9.71%	11.46%	10.95%	17.52%	6.70%	10.79%	12.91%
Pre Tax Income Margin	2.09%	6.83%	-2.32%	14.45%	10.05%	14.06%	15.23%	20.62%	7.49%	12.85%	15.33%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	2.38	6.23	-0.91	14.10	9.43	11.77	12.04	19.64	5.65	9.60	10.48
NOPAT to Interest Expense	2.55	8.85	-0.70	12.13	4.88	8.78	7.94	15.83	4.17	7.22	7.99
EBIT Less CapEx to Interest Expense	1.24	4.23	-3.41	10.24	7.57	9.36	9.74	16.23	4.09	7.92	8.89
NOPAT Less CapEx to Interest Expense	1.40	6.85	-3.20	8.27	3.02	6.37	5.64	12.42	2.60	5.54	6.39
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	608.08%	650.54%	240.87%	209.25%	165.68%	131.41%	89.28%	75.00%	76.96%	80.26%	78.18%
Augmented Payout Ratio	608.08%	650.54%	240.87%	209.25%	194.59%	186.32%	125.53%	115.29%	121.05%	123.25%	121.17%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from CLOROX CO /DE/ (NYSE: CLX) across the last four years of quarterly statements, focusing on profitability, cash flow, liquidity, and leverage.

Profitability recovery in the latest quarter: Net income from continuing operations for Q2 2026 was $161 million, lifting recent quarterly profitability from the prior quarter.
Solid gross margin in the latest quarter: Q2 2026 gross profit was about $722 million on revenue of $1.673 billion, ≈43% gross margin on that period’s top line.
Strong operating cash flow supports liquidity: Q2 2026 net cash from continuing operating activities was roughly $311 million, indicating solid cash generation from core operations.
Balanced balance sheet with reasonable liquidity: Cash & equivalents around $227 million; Total assets about $5.613 billion; Total liabilities about $5.578 billion; Total equity around $35 million as of the latest quarter, suggesting assets largely cover liabilities with a modest equity cushion.
Historical reporting nuances: There have been occasional restatements or adjustments in 2024–2025 quarters, which can complicate year-over-year comparisons.
Capital allocation timing varies: Dividend and share-repurchase activity has fluctuated by quarter, affecting cash flow timing but reflecting ongoing capital-allocation decisions.
One-time impairment headwind in 2023: A notable impairment charge of $445 million in Q3 2023 weighed on earnings and contributed to earnings volatility that year.
Cash outflows from financing activities: Financing outflows have been meaningful in multiple quarters due to buybacks and dividends (for example, about $210 million net outflow in Q2 2026 and around $279 million in Q4 2025), reducing cash on hand in those periods.

05/23/26 10:10 AM ETAI Generated. May Contain Errors.

Clorox Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Clorox's financial year ends in June. Their financial year 2025 ended on June 30, 2025.

Over the last 10 years, Clorox's net income changed from $0.00 in 2015 to $824 million in 2025, a change of 82,400,000,000.0%. View Clorox's forecast to see where analysts expect Clorox to go next.

Clorox's total operating income in 2025 was $1.08 billion, based on the following breakdown:

Total Gross Profit: $3.21 billion
Total Operating Expenses: $2.13 billion

Over the last 10 years, Clorox's total revenue changed from $0.00 in 2015 to $7.10 billion in 2025, a change of 710,400,000,000.0%.

Clorox's total liabilities were at $5.08 billion at the end of 2025, a 3.4% decrease from 2024, and a 25.5% increase since 2015.

In the past 10 years, Clorox's cash and equivalents has ranged from $111 million in 2019 to $871 million in 2020, and is currently $167 million as of their latest financial filing in 2025.

Over the last 10 years, Clorox's book value per share changed from 0.90 in 2015 to 2.60 in 2025, a change of 189.5%.

Related Companies

Financial statements for NYSE:CLX last updated on 5/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Clorox (CLX) Financials

Financials Breakdown Chart

Key Financial Trends

Clorox Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Clorox (CLX) Financials

Annual Income Statements for Clorox

Quarterly Income Statements for Clorox

Annual Cash Flow Statements for Clorox

Quarterly Cash Flow Statements for Clorox

Annual Balance Sheets for Clorox

Quarterly Balance Sheets for Clorox

Annual Metrics And Ratios for Clorox

Quarterly Metrics And Ratios for Clorox

Financials Breakdown Chart

Key Financial Trends

Clorox Financials - Frequently Asked Questions

When does Clorox's fiscal year end?

How has Clorox's net income changed over the last 10 years?

What is Clorox's operating income?

How has Clorox's revenue changed over the last 10 years?

How much debt does Clorox have?

How much cash does Clorox have?

How has Clorox's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools